Neuromodulation Parameter Efficacy
ConditionChronic Pain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorAlberta Health Services, Calgary
About this trial
The objective of this study is to determine the efficacy of neuromodulation using various stimulation paradigms in the treatment of several disorders including chronic pain.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients who are candidates for, and have been consented for, implantation of a neuromodulation device.
Disqualifiers
Non-English speaking
Trial design
Design model
Crossover
Treatments tested in this trial
Stimulation parameters
Other interventionDifferent device stimulation parameters
Treatment groups
20 Participants
are divided into 2 treatment groupsGroup A: Industry standard stimulationActive comparator 1 intervention
Group B: Experimental stimulationSham comparator 1 intervention
Trial outcomes
Primary outcomes
1
Change in baseline pain measures
Pain outcomes measured using visual analogue scale
Time frame
6 monthsSecondary outcomes
1
Effect of stimulation on quality of life
As measured using EQ-5D-3L
Time frame
6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov